Chad M. Cohen, Chief Financial Officer at Adaptive Biotechnologies Corp (ADPT), sold 148,800 shares at $62.96 ($9.3M) on 2021-01-12, disclosed to the SEC on 2021-01-13.
Open-market sale of $9.3M ADPT by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $62.25 | 39,973 | $2.5M | 26.7% |
| 2 | $62.25 | 39,973 | $2.5M | 26.7% |
| 3 | $62.96 | 33,827 | $2.1M | 22.9% |
| 4 | $62.96 | 33,827 | $2.1M | 22.9% |
| 5 | $63.73 | 1,200 | $76K | 0.8% |
| Total | $62.58 avg | 148,800 |
| $9.3M |
| 100% |
| Filing → |
| ADPT | SELL | 2021-10-07 | $324K | — | Filing → |
| ADPT | SELL | 2021-09-09 | $940K | — | Filing → |
| ADPT | SELL | 2021-08-12 | $804K | — | Filing → |